FATE Operating Income Growth
Fate Therapeutics Inc · Operating Income Growth
FATE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported15.78%period ending
FATE Quarterly Operating Income YoY % (-41.04% → 15.78%)
Year-over-year change
High-resolution chart · PNG
FATE operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 15.7812% | |
| 20.0581% | |
| 43.7698% | |
| 33.6827% | |
| 18.0001% | |
| 19.1666% | |
| -28.441% | |
| -2.1412% | |
| 27.9421% | |
| -78.6094% | |
| 25.3714% | |
| 40.6431% | |
| 24.7193% | |
| 61.6045% | |
| 7.1532% | |
| -58.1587% | |
| -77.6631% | |
| -61.1491% | |
| -107.7368% | |
| -73.4779% | |
| -62.9533% | |
| -33.9731% | |
| -14.86% | |
| -16.1068% | |
| -19.1953% | |
| -68.698% | |
| -73.6933% | |
| -62.4671% | |
| -22.8462% | |
| -45.4817% | |
| -36.7282% | |
| -61.4313% | |
| -104.8589% | |
| -40.9488% | |
| -59.9686% | |
| -23.2566% | |
| -19.5652% | |
| -25.9601% | |
| -10.735% | |
| -32.5695% | |
| -10.8894% | |
| -8.083% | |
| -16.3049% | |
| -5.7487% | |
| -19.5033% | |
| -5.5788% | |
| -21.2362% | |
| -16.2393% | |
| -41.4851% | |
| -106.7044% | |
| -21.2166% | |
| -41.0411% |